Related by context. Frequent words. (Click for all words.) 79 Phase 2a 78 phase IIa 77 Phase 2a clinical 76 phase IIb 76 Phase 1b 75 Phase IIa 75 Phase IIa clinical 75 Phase Ib 75 Phase 2b study 74 Phase 1b clinical 74 Phase IIa trial 74 Phase IIb clinical 73 Phase 2b 73 Phase 2a trial 72 Phase IIb 72 Phase 2b clinical 72 Phase III 71 Phase III clinical 71 Phase II 70 Phase IIb trial 70 pivotal Phase III 69 dose escalation trial 67 Phase 2b trial 67 multiple ascending dose 67 dose escalation study 67 Phase III pivotal 66 pivotal Phase 65 HGS ETR1 65 Phase III clinical trials 65 confirmatory Phase 3 65 ISIS # 65 randomized Phase 64 PXD# 64 PRX # 64 denufosol 63 Phase III trials 63 placebo controlled 63 INCB# [002] 63 clinical trial 63 multicenter clinical 63 laquinimod 63 NGX# 63 single ascending dose 62 eltrombopag 62 ALKS 62 AP# [003] 62 talactoferrin 62 belinostat 62 PS# [001] 62 IDX# 62 multicenter randomized double 62 ZYBRESTAT 61 BAY #-# 61 sapacitabine 61 ProLindac 61 randomized placebo controlled 61 dose escalation 61 pharmacokinetic 61 Azixa 61 GRN#L 61 ASA# 61 OXi# 61 randomized controlled 60 double blind placebo 60 IMGN# 60 relapsed multiple myeloma 60 perifosine 60 MDV# 60 Phase 60 CRx 60 preclinical studies 60 preclinical 60 Preclinical studies 60 HspE7 60 ofatumumab 60 mipomersen 60 CoFactor 60 elagolix 60 XL# [003] 60 microplasmin 60 randomized double 60 Zerenex 60 initiate Phase 60 LymphoStat B 59 ADX# 59 investigational compound 59 daclizumab 59 randomized controlled clinical 59 TG# [001] 59 picoplatin 59 vicriviroc 59 GVAX 59 methylnaltrexone 59 tolerability 59 pharmacodynamics 59 ACTEMRA 59 TRIOLEX 59 AACR NCI EORTC 59 RG# [001] 59 unblinded 59 investigational oral